Skip to main content
Terug
Watch Compare

Organogenesis Holdings Inc.

Datakwaliteit: 100%
ORGO
Nasdaq Manufacturing Chemicals
€ 2,30
▼ € 0,10 (-3,97%)
Marktkapitalisatie: 295,23 M
Prijs
€ 2,30
Marktkapitalisatie
295,23 M
Dagbereik
€ 2,23 — € 2,43
52-Weeksbereik
€ 2,21 — € 7,08
Volume
1.406.441
Openen € 2,40
50D / 200D Gem.
€ 3,21
28,50% below
50D / 200D Gem.
€ 4,27
46,22% below

Quick Summary

Belangrijkste Punten

Revenue grew 4,78% annually over 5 years — modest growth
Earnings grew 4201,05% over the past year
ROE of 15,17% — decent returns on equity
Negative free cash flow of -24,46 M
P/E of 7,97 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 12,26%

Groei

Revenue Growth (5Y)
4,78%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)17,04%
Earnings (1Y)4201,05%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
15,17%
Boven sectorgemiddelde (-53,41%)
ROIC8,65%
Net Margin6,56%
Op. Margin7,92%

Veiligheid

Debt / Equity
N/A
Current Ratio3,32
Interest Coverage19,59

Waardering

PE (TTM)
7,97
Boven sectorgemiddelde (-1,48)
P/B Ratio1,16
EV/EBITDA3,86
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E 8,0 -1,5
P/B 1,2 1,6
ROE % 15,2 -53,4
Net Margin % 6,6 -41,5
Rev Growth 5Y % 4,8 1,8
D/E — 0,3

ETFs Holding This Stock

TRACX TRACX
0,29% weight
PSVDX PSVDX
0,29% weight
TASVX TASVX
0,29% weight
TSVRX TSVRX
0,29% weight
TSVAX TSVAX
0,29% weight
TSVQX TSVQX
0,29% weight
PSVKX PSVKX
0,29% weight
EES logo EES WisdomTree U.S. SmallCap Fund
0,12% weight
QWVOX QWVOX
0,07% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,04% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17,04% Revenue Growth (3Y) 14,13%
Earnings Growth (1Y) 4201,05% Earnings Growth (3Y) 173,66%
Revenue Growth (5Y) 4,78% Earnings Growth (5Y) -20,96%
Profitability
Revenue (TTM) 564,17 M Net Income (TTM) 37,03 M
ROE 15,17% ROA 7,63%
Gross Margin N/A Operating Margin 7,92%
Net Margin 6,56% Free Cash Flow (TTM) -24,46 M
ROIC 8,65% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,32
Interest Coverage 19,59 Asset Turnover 1,16
Working Capital 209,43 M Tangible Book Value 216,41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 7,97 Forward P/E N/A
P/B Ratio 1,16 P/S Ratio 0,52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 3,86 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,29%
Market Cap 295,23 M Enterprise Value 231,49 M
Per Share
EPS (Diluted TTM) 0,15 Revenue / Share 4,39
FCF / Share -0,19 OCF / Share -0,08
EPS CAGR (1Y) N/A EPS CAGR (5Y) -32,20%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2,51% FCF Conversion -66,05%
SBC-Adj. FCF -36,15 M Growth Momentum 12,26

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 564,17 M 482,04 M 433,14 M 450,89 M 468,06 M
Net Income 37,03 M 861.000,0 4,95 M 15,53 M 94,90 M
EPS (Diluted) 0,15 -0,01 0,04 0,12 0,71
Gross Profit — 366,30 M 326,66 M 345,87 M 353,86 M
Operating Income 44,69 M -1,28 M 12,53 M 22,30 M 72,92 M
EBITDA — — — — —
R&D Expenses 44,54 M 50,27 M 44,38 M 39,76 M 30,74 M
SG&A Expenses 326,24 M 294,51 M 269,75 M 283,81 M 250,20 M
D&A 15,27 M 13,62 M — — —
Interest Expense -2,28 M 1,54 M 2,19 M 2,01 M 7,24 M
Income Tax 9,94 M -3,67 M 5,45 M 4,75 M -31,12 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 598,73 M 497,89 M 460,03 M 449,36 M 443,26 M
Total Liabilities 164,81 M 112,57 M 181,36 M 183,69 M 201,22 M
Shareholders' Equity 300,13 M 262,90 M 278,66 M 265,67 M 242,04 M
Total Debt — — 66,56 M 71,25 M 74,06 M
Cash & Equivalents 93,68 M 135,57 M 103,84 M 102,48 M 113,93 M
Current Assets 362,19 M 285,94 M 225,04 M 222,61 M 226,98 M
Current Liabilities 100,12 M 77,48 M 80,51 M 75,02 M 82,01 M